Core Compounders Should Do This With Walmart

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • WMT has dropped from $135 to $106 even as high-margin ad and marketplace segments surge between 38% and 52%, resetting the entry point for long-term compounders.

  • WMT trails SPY by 16 percentage points year to date, yet 37 of 43 analysts rate it a Buy targeting $128.

  • The most widely read finance newsletter on Substack isn't published by a bank, it's Doomberg, where 383,000+ readers get the energy and macro analysis the mainstream press misses. 24/7 Wall St. readers save 17% on their first year here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Core Compounders Should Do This With Walmart

© Andrei Stanescu / Getty Images

At $106.49, Walmart (NYSE:WMT | WMT Price Prediction) trades at a level that reframes the risk/reward math for long-term compounders. The stock has slid from a 52-week high of $134.84 back into the low $100s, resetting the setup for anyone evaluating a core position.

Walmart runs the largest retailer in the world, anchored by U.S. supercenters, Sam’s Club, and a fast-growing international footprint. The story that matters now is how much of the profit engine sits outside four walls. Advertising, marketplace fees, and Walmart+ memberships are scaling on top of grocery traffic, and management is reinvesting tariff refunds into price to widen the moat.

Why the Pullback Rewires the Setup

Shares are down 6.64% over the past week and 3.81% year to date, even after Q2 beat expectations. That gap versus the index is what creates the entry.

Higher-Margin Flywheel Is Doing the Heavy Lifting

Q2 FY27 delivered adjusted EPS of $0.81 against a $0.73 estimate on revenue of $187.94 billion, up 5.94% year over year. Global advertising rose 38%, Walmart Connect climbed 43%, membership fees grew 17% globally, and U.S. marketplace sales jumped 52%. CFO John David Rainey said “E-commerce and related businesses offer compelling growth, and we are consistently generating strong incremental margins.”

Management raised the full-year outlook to 4% to 5% sales growth and adjusted EPS of $2.80 to $2.87, and analysts carry a $128.43 target. With 9 Strong Buy, 28 Buy, 5 Hold, and 1 Sell ratings, sell-side conviction is high, though targets remain just one input.

Valuation and Consumer Cracks Are Real

The bear case starts with price. Walmart trades at 39 times earnings and 36 times forward earnings, with a 0.89% dividend yield and a 1.76% free cash flow yield. That is a full multiple for a business with a 3.07% net margin. Net income fell 9.39% year over year in Q2, and inventory is up 6.7%.

Consumer sentiment sits at 49.5, well under the 60 recessionary threshold, and July retail sales dropped 0.6% month over month. Maximum Fair Pricing pharmacy rules are already carving 125 basis points off U.S. comps.

Why Patience Has a Place Too

The hold case is that Q3 guidance calls for adjusted EPS of just $0.62 to $0.64 as tariff refund reinvestment pressures margins. Buyers who wait for a print in the mid $90s near the 52-week low of $94.62 would get a cleaner valuation and a clearer read on holiday demand.

Data That Frames the Decision

Walmart currently trades at $106.49 against a consensus target of $128.43, implying roughly 21% upside across 43 covering analysts. Over the past year the stock has gained 10.9% versus 18.31% for the S&P 500, and year to date it trails badly at negative 3.81% against the S&P’s 11.96% gain. The $0.99 forward annual dividend extends a payout streak that has climbed every year since 1999.

Why This Price Is a Compounder’s Entry

At $106.49, the setup favors long-term compounders. Here is why.

The path to appreciation runs through mix shift. Ads, membership, and marketplace are growing 20% to 50%, expanding incremental margins at twice the rate of the base business. As those revenue lines compound, the P/E argument softens because forward earnings power keeps repricing higher.

Dollar-cost averaging fits this setup. Building exposure incrementally from the recent pullback out of $135 toward $106 avoids timing a Q3 margin dip while still capturing the reinvestment cycle. If shares slide toward the $94 area, accumulation becomes more attractive on a risk/reward basis; if they rally through $128, the thesis is already working.

What would invalidate the call: sustained comp deceleration below 2%, an ad-growth stall under 25%, or free cash flow rolling over. Absent those, this remains the kind of quality name long-term investors tend to consider on weakness.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

MRNA Vol: 33,193,565
SMCI Vol: 30,479,705
CDW
CDW Vol: 784,378
COIN Vol: 6,196,602
AMD
AMD Vol: 11,811,639

Top Losing Stocks

CTRA Vol: 73,319,495
ALB Vol: 1,002,830
LULU Vol: 1,909,782
TGT Vol: 3,727,120
EQR Vol: 17,443,069